Cetuximab and Cisplatin Show Different Combination Effect in Nasopharyngeal Carcinoma Cells Lines via Inactivation of EGFR/AKT Signaling Pathway

Cetuximab and Cisplatin Show Different Combination Effect in Nasopharyngeal Carcinoma Cells Lines via Inactivation of EGFR/AKT Signaling Pathway

Nasopharyngeal carcinoma (NPC) is a common malignant cancer in South China. Cisplatin is a classical chemotherapeutic employed for NPC treatment. Despite the use of cisplatin-based concurrent chemoradiotherapy, distant failure still confuses clinicians and the outcome of metastatic NPC remains disap...

Full description

Bibliographic Details
Main Authors: Gu, Jiajia, Yin, Li, Wu, Jing, Zhang, Nan, Huang, Teng, Ding, Kai, Cao, Haixia, Xu, Lin, He, Xia
Format: Online
Language:English
Published: Hindawi Publishing Corporation 2016
Online Access:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894995/

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4894995/

Similar Items